Preloader

Glenmark concludes post marketing surveillance (PMS) study on Favipiravir, Health News, ET HealthWorld

Mumbai (Maharashtra): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. The PMS study…